Fountain Healthcare Partners

Neuromod closes €10.5m Series B financing led by Fountain Healthcare Partners

– IRELAND, Dublin –  Neuromod Devices Limited, the Irish medical device company specialising in the treatment of tinnitus, a chronic condition that affects 10-15% of the global population and commonly described as ‘ringing in the ears’, today announced having raised €10.5 million in an oversubscribed Series B financing led by majority investor Fountain Healthcare Partners, with participation from existing investors Moffett Investment Holdings and Medical Device Resources, with venture-debt provided by Kreos Capital and Silicon Valley Bank.…

Priothera strengthens its Board of Directors along with raising €30m Series A financing co-led by Fountain Healthcare Partners and HealthCap

– IRELAND, Dublin –  Priothera Limited, a clinical-stage company developing orally applied sphingosine 1 phosphate receptor modulators for haematological malignancies, today announced the closing of a €30 million Series A financing round co-led by Fountain Healthcare Partners and HealthCap alongside funds managed by Tekla Capital Management, LLC as well as EarlyBird Venture Capital.…

Inotrem announces Ena Prosser to its Board along with raising €19m financing from Fountain Healthcare Partners and Kreos Capital

– FRANCE, Paris –  Inotrem S.A., a biotechnology company specialized in the development of immunotherapies targeting the TREM-1 pathway with potential applications for acute and chronic inflammatory syndromes, today announced a €5M capital increase financed by Fountain Healthcare Partners, a leading Irish venture capital firm with offices in Dublin and New York.…

NeRRe Therapeutics strengthens its Board along with raising £23m Series B financing

– UK, Stevenage – NeRRe Therapeutics, a clinical-stage company developing a unique portfolio of neurokinin receptor antagonists for the treatment of common, chronic and debilitating conditions caused by neuronal hypersensitivity, announced it has raised £23 million in an oversubscribed Series B financing round.…

Talent4Boards
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.